JP2023528713A5 - - Google Patents
Info
- Publication number
- JP2023528713A5 JP2023528713A5 JP2022551555A JP2022551555A JP2023528713A5 JP 2023528713 A5 JP2023528713 A5 JP 2023528713A5 JP 2022551555 A JP2022551555 A JP 2022551555A JP 2022551555 A JP2022551555 A JP 2022551555A JP 2023528713 A5 JP2023528713 A5 JP 2023528713A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently
- pharmaceutically acceptable
- stereoisomer
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062983438P | 2020-02-28 | 2020-02-28 | |
| US62/983,438 | 2020-02-28 | ||
| US202063076113P | 2020-09-09 | 2020-09-09 | |
| US63/076,113 | 2020-09-09 | ||
| US202063117074P | 2020-11-23 | 2020-11-23 | |
| US63/117,074 | 2020-11-23 | ||
| US202163147982P | 2021-02-10 | 2021-02-10 | |
| US63/147,982 | 2021-02-10 | ||
| PCT/US2021/019973 WO2021174046A1 (en) | 2020-02-28 | 2021-02-26 | Gpr40 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528713A JP2023528713A (ja) | 2023-07-06 |
| JP2023528713A5 true JP2023528713A5 (https=) | 2024-02-21 |
Family
ID=77490353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551555A Pending JP2023528713A (ja) | 2020-02-28 | 2021-02-26 | Ｇｐｒ４０アゴニスト |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230151037A1 (https=) |
| EP (1) | EP4110760A4 (https=) |
| JP (1) | JP2023528713A (https=) |
| CN (1) | CN115867536A (https=) |
| AU (1) | AU2021225966A1 (https=) |
| CA (1) | CA3173732A1 (https=) |
| TW (1) | TW202140424A (https=) |
| UY (1) | UY39106A (https=) |
| WO (1) | WO2021174046A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220150270A (ko) | 2019-10-07 | 2022-11-10 | 칼리오페, 인크. | Gpr119 효능제 |
| TW202140440A (zh) | 2020-02-28 | 2021-11-01 | 美商克力歐普股份有限公司 | Gpr40激動劑 |
| EP4337202A4 (en) | 2021-06-18 | 2025-04-02 | Aligos Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR TARGETING PD-L1 |
| EP4448512A4 (en) | 2021-12-16 | 2025-11-19 | Aligos Therapeutics Inc | METHODS AND COMPOSITIONS FOR TARGETING PD-L1 |
| CN118724767A (zh) * | 2023-03-28 | 2024-10-01 | 南京华狮新材料有限公司 | 一种氨基酸衍生物及其制备方法和作为中间体合成l-草铵膦的方法 |
| CN116178281B (zh) * | 2023-04-27 | 2023-07-21 | 中国药科大学 | 一种双功能免疫抑制剂及其制备方法和应用 |
| WO2025136929A1 (en) * | 2023-12-19 | 2025-06-26 | Kallyope, Inc. | Gpr40 agonists |
| WO2025137310A1 (en) * | 2023-12-22 | 2025-06-26 | Kallyope, Inc. | Crystalline gpr40 agonist and methods of making |
| WO2026019701A1 (en) * | 2024-07-15 | 2026-01-22 | Venenum Biodesign, LLC | Substituted phenylsulfonamides as mgat2 inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2558585C (en) * | 2004-02-27 | 2010-10-12 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| JP4875978B2 (ja) * | 2004-03-15 | 2012-02-15 | 武田薬品工業株式会社 | アミノフェニルプロパン酸誘導体 |
| US8119617B2 (en) * | 2006-08-23 | 2012-02-21 | Novartis Ag | aSMase inhibitors |
| RU2627703C2 (ru) * | 2010-07-23 | 2017-08-10 | Конекшис Лайф Сайенсиз Пвт. Лтд. | Агонисты gpr40 |
| WO2013122028A1 (ja) * | 2012-02-13 | 2013-08-22 | 武田薬品工業株式会社 | 芳香環化合物 |
| EP3076959B1 (en) * | 2013-12-04 | 2018-07-04 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| WO2015119899A1 (en) * | 2014-02-06 | 2015-08-13 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
| TW201613878A (en) * | 2014-07-09 | 2016-04-16 | Janssen Pharmaceutica Nv | Pyrazine GPR40 agonists for the treatment of type II diabetes |
| US20220226298A1 (en) * | 2019-05-29 | 2022-07-21 | Kallyope, Inc. | Gpr40 agonists |
-
2021
- 2021-02-26 WO PCT/US2021/019973 patent/WO2021174046A1/en not_active Ceased
- 2021-02-26 CN CN202180031973.XA patent/CN115867536A/zh active Pending
- 2021-02-26 CA CA3173732A patent/CA3173732A1/en active Pending
- 2021-02-26 JP JP2022551555A patent/JP2023528713A/ja active Pending
- 2021-02-26 AU AU2021225966A patent/AU2021225966A1/en not_active Abandoned
- 2021-02-26 TW TW110106878A patent/TW202140424A/zh unknown
- 2021-02-26 EP EP21759537.0A patent/EP4110760A4/en not_active Withdrawn
- 2021-02-28 US US17/802,910 patent/US20230151037A1/en not_active Abandoned
- 2021-03-01 UY UY0001039106A patent/UY39106A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023528713A5 (https=) | ||
| JP2023516187A5 (https=) | ||
| JP2023516235A5 (https=) | ||
| JP2021176846A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2025500308A5 (https=) | ||
| ES2546063T3 (es) | Agentes de enlace a amiloides | |
| JP2007528417A5 (https=) | ||
| JP2021527125A5 (https=) | ||
| JP2021512913A5 (https=) | ||
| BRPI0212775B1 (pt) | composto de 1,2,4-triazol e medicamento | |
| JP2021535164A5 (https=) | ||
| RU2004117545A (ru) | Аминопиримидины и пиридины | |
| JP2022533069A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| WO2001024786A1 (en) | Preventive or therapeutic drugs for diabetes | |
| JP2023525571A5 (https=) | ||
| PT99351A (pt) | Processo para a preparacao de derivados de tiazolidinodiona | |
| IL286902B1 (en) | Pyrrole compounds | |
| BR112019020075A2 (pt) | composto, e, composição farmacêutica | |
| JP2022533939A5 (https=) | ||
| JP2023553428A5 (https=) | ||
| JP2021534254A5 (ja) | 心臓弁疾患を治療するための医薬組成物 | |
| BRPI0615690B1 (pt) | compostos heterocíclicos de hidroxamato, seus usos e composição farmacêutica | |
| JP2025509134A5 (https=) | ||
| JP2023531495A5 (https=) |